Eurofins Transplant Genomics
Roy First is currently the Chief Medical Officer at Transplant Genomics Inc. Roy has extensive experience in the field, previously serving as the Vice President, Therapeutic Area Head Transplantation at Astellas Pharma Global Development. Prior to that, Roy was a Professor of Medicine at the University of Cincinnati Medical Center. Roy First holds a Bachelor of Medicine, Bachelor of Surgery (M.B.B.S.) degree from the University of the Witwatersrand with a focus on Transplant Nephrology.
This person is not in the org chart
This person is not in any offices
Eurofins Transplant Genomics
Transplant Genomics is committed to improving organ transplant outcomes with noninvasive serial monitoring guided by genomics.